XV European Meeting on Hypertension

Meeting Highlights

• VALUE: Valsartan compared to amlodipine reduces new-onset diabetes in high-risk hypertensive patients
• Plaque number at baseline predictive of events in the ELSA study
• PERFECT: Perindopril improves endothelial function, may explain EUROPA results
• Office blood pressure predictive beyond ambulatory blood pressure in OvA subanalysis
• Non-CV mortality increased with DBP below 70 mm Hg in Syst-Eur analysis
• Monotherapy in VALUE: Similar outcome reductions to main study, effect larger
• Message from Prof. Giuseppe Mancia, Chairperson of the 15th European Meeting, held June 17-21, 2005 in Milan, Italy
• Manidipine performs better than amlodipine in hypertensive diabetics with early nephropathy patients
• Intensified treatment
• CV events reduced with more intense treatment in high risk patients
• Comments by Prof. Michael Alderman, President of the International Society of Hypertension
• Comments by Prof. Lars Lindholm, President-elect of the International Society of Hypertension
• Changes in renal function seen with increasingly elevated blood pressures
• Cardiovascular Remodeling and Hypertension: Its Effects and Clinical Value
• ALLHAT: Differential effects for amlodipine compared to lisinopril
• ACTION subgroup analysis: Nifedipine GITS more beneficial in hypertensive patients with CAD
• ACTION subgroup analysis: Nifedipine GITS more beneficial in hypertensive patients with CAD